Incidence rates for recurrent VTE, major bleeding, and all-cause mortality
| Event . | Overall cohort . | Never treated . | Treated, on treatment . | Treated, off treatment . |
|---|---|---|---|---|
| Total p-y | 1975 | 376 | 1132 | 467* |
| Recurrent VTE | ||||
| Events per 100 p-y | 104 | 35 | 38 | 31 |
| Relative 95% CI | 5.3 (5.1-5.5) | 9.3 (8.4-10.3) | 3.4 (3.2-3.6) | 6.6 (6.0-7.2) |
| Major bleeding | ||||
| Events per 100 p-y | 86 | 24 | 35 | 27 |
| Relative 95% CI | 4.4 (4.2-4.6) | 6.4 (5.8-7.1) | 3.1 (2.9-3.3) | 5.8 (5.3-6.4) |
| All-cause mortality | ||||
| Events per 100 p-y | 136 | 82 | 65 | 109 |
| Relative 95% CI | 13.0 (12.4-13.6) | 21.8 (19.7-24.1) | 5.7 (5.4-6.0) | 23.3 (21.3-25.3) |
| Event . | Overall cohort . | Never treated . | Treated, on treatment . | Treated, off treatment . |
|---|---|---|---|---|
| Total p-y | 1975 | 376 | 1132 | 467* |
| Recurrent VTE | ||||
| Events per 100 p-y | 104 | 35 | 38 | 31 |
| Relative 95% CI | 5.3 (5.1-5.5) | 9.3 (8.4-10.3) | 3.4 (3.2-3.6) | 6.6 (6.0-7.2) |
| Major bleeding | ||||
| Events per 100 p-y | 86 | 24 | 35 | 27 |
| Relative 95% CI | 4.4 (4.2-4.6) | 6.4 (5.8-7.1) | 3.1 (2.9-3.3) | 5.8 (5.3-6.4) |
| All-cause mortality | ||||
| Events per 100 p-y | 136 | 82 | 65 | 109 |
| Relative 95% CI | 13.0 (12.4-13.6) | 21.8 (19.7-24.1) | 5.7 (5.4-6.0) | 23.3 (21.3-25.3) |
Values are expressed as number of events per 100 p-y with relative 95% CIs.
p-y includes time before treatment initiation and time after treatment withdrawal.